A Remarkable Partnership Condenses National Vaccination Plan by Two Months
State and federal governments are rapidly expanding eligibility for COVID-19 vaccines, after weeks of delay and confusion associated with uncertain and inadequate supplies to local pharmacies and other vaccinators. Read on to learn more about the major changes underlying the new plans and a hopeful, historic collaboration.
|
Vaccine Status: Three Approved, Two Closing In
The approval of Johnson & Johnson’s vaccine brought the number of authorized COVID-19 vaccines in the U.S. to three and substantially eased supply challenges. What about the other vaccines in development? What impact will they have? Learn which of the 21 vaccines currently in final stages of testing are likely to make a difference in the United States in the coming months.
|